azaserine has been researched along with Carcinoma--Ehrlich-Tumor* in 29 studies
2 review(s) available for azaserine and Carcinoma--Ehrlich-Tumor
Article | Year |
---|---|
Some antineoplastic antibiotics.
Topics: Adenocarcinoma; Amino Sugars; Animals; Antibiotics, Antineoplastic; Azaserine; Benzazepines; Bleomycin; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Cricetinae; Dactinomycin; Daunorubicin; DNA; Dogs; Glycosides; Haplorhini; Humans; Leukemia L1210; Liver Neoplasms; Lymphoma; Mice; Mitomycins; Naphthacenes; Plicamycin; Pyrroles; Rats; RNA; Sarcoma 180; Streptonigrin; Streptozocin | 1972 |
BIOCHEMISTRY OF CANCER (METABOLIC ASPECTS).
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Azaguanine; Azaserine; Carcinoma, Ehrlich Tumor; DNA; DNA, Neoplasm; Floxuridine; Fluorouracil; Folic Acid; Glutamine; Leukemia L1210; Mercaptopurine; Methotrexate; Mitomycin; Neoplasms; Neoplasms, Experimental; Pharmacology; Purines; Puromycin; Pyrimidines; Research; RNA; RNA, Neoplasm; Thioguanine; Thiouracil | 1963 |
27 other study(ies) available for azaserine and Carcinoma--Ehrlich-Tumor
Article | Year |
---|---|
Synthesis, pharmacological activity and comparative QSAR modeling of 1,5-N,N'-substituted-2-(substituted naphthalenesulphonyl) glutamamides as possible anticancer agents.
Based on our earlier QSAR study, a series of 1, 5-N,N'-substituted-2-(substituted naphthalenesulphonyl) glutamamides were synthesized as possible anticancer agents. Anticancer activities of these synthesized compounds were evaluated in vivo on Swiss Albino mice against Ehrlich Ascites Carcinoma (EAC) cells where inhibitions of tumor cell and tumor weight were considered as biological activity parameters. A comparative QSAR study was done with a set of descriptors and logarithm of tumor cell inhibition. The result shows the importance of topological parameters like ETSA and RTSA indices as well as electronic parameter like Wang-Ford charges of different atoms. Electrophilic attack at atom number 5 and increased number of chlorine atom may be favorable whereas presence of methoxy group at the atom number 8 in naphthalene ring may be detrimental to the activity. Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Glutamine; Male; Mice; Models, Molecular; Molecular Structure; Neoplasm Transplantation; Neoplasms, Experimental; Quantitative Structure-Activity Relationship; Stereoisomerism; Structure-Activity Relationship | 2010 |
Possible anticancer agents: QSAR analogs of glutamamide: synthesis and pharmacological activity of 1,5-N,N'-disubstituted-2-(substituted benzenesulphonyl) glutamamides.
Based on our earlier QSAR prediction, a series of designed QSAR analogs of 1,5-N,N'-disubstituted-2-(substituted benzenesulphonyl) glutamamides were synthesized as possible anticancer agents. Inhibitions of tumor cell proliferation of the compounds were tested in tumor cell line IMR-32. Anticancer activities of these compounds were also evaluated on Swiss Albino mice against Ehrlich Ascites Carcinoma (EAC) cells. Tumor weight inhibition and tumor cell inhibition were considered as anticancer activity parameters. QSAR analysis of these compounds was performed on the basis of a set of descriptors like physicochemical, topological, quantum chemical and DRAGON whole molecular descriptors. The study showed that the increase of length of substituent at R(2) position and the increase of dipole moment of the molecule decrease the anticancer activity of these compounds, presence of bromine atom at R(3) position and hydrophilic substitution at R(2) position are advantageous to the activity. Nucleophilic attack at atom number 14 is advantageous and electrophilic attack at atom number 15 is detrimental to anticancer activity. Atom number 2 is important and may be involved in dispersive interactions of the compounds with enzymes. The results offer an opportunity for further tailoring of these analogs for an active member. Topics: Amides; Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Glutamates; Humans; Mice; Quantitative Structure-Activity Relationship; Tumor Burden | 2009 |
Effect of lowered intracellular ATP and GTP concentrations on purine ribonucleotide synthesis and interconversion.
The effects of lowered intracellular ATP and GTP concentrations on enzymes of purine ribonucleotide synthesis and intercoversion were studied using intact Ehrlich ascites tumor cells. The apparent rates of phosphoribosyl pyrophosphate synthetase (EC 2.7.6.1) and of inosinate dehydrogenase (EC 1.2.1.14) were increased in cells containing lowered purine nucleotide concentrations, but apparent activities of amidophosphoribosyltransferase (EC 2.4.2.14), the purine phosphoribosyltransferases, and other enzymes of purine ribonucleotide interconversion were not affected. Topics: Adenine Phosphoribosyltransferase; Amidophosphoribosyltransferase; Animals; Antibiotics, Antineoplastic; Azaserine; Carcinoma, Ehrlich Tumor; Formaldehyde; Glycine; Hypoxanthine Phosphoribosyltransferase; Mice; Mycophenolic Acid; Phosphoribosyl Pyrophosphate; Purine Nucleotides; Ribose-Phosphate Pyrophosphokinase; Ribosemonophosphates | 1977 |
The effect of cyclic nucleotides on cellular ATP levels and ribosomal RNA synthesis in Ehrlich ascites cells.
Amino acid starvation of Ehrlich ascites cells leads to a significant decrease of the intracellular ATP concentration concomitant with a marked decrease in nucleolar RNA polymerase activity. Addition of 8-bromoguanosine 3':5'-monophosphate (br8cGMP) to the amino-acid-deficient culture medium increased the cellular ATP levels and restored the rRNA synthesis capacity of nucleoli to control levels. Exogenous br8cAMP overcame the effects of br8cGMP. Administration of br8cAMP to exponentially growing ascites cells resulted in a shrinkage of ATP levels and in an inhibition of nucleolar RNA synthesis similar to that observed under shift-down conditions. These effects of br8cAMP could be antagonized by exogenous br8cGMP or hypoxanthine. Since the br8cGMP-induced increase in the total adenine nucleotides was abolished in the presence of azaserine (an inhibitor of the amidation of formylglycineamide ribonucleotide) it is concluded that cyclic nucleotides exert at least a part of their regulatory effects on cell proliferation by regulating nucleotide biosynthesis de novo. Topics: Adenosine Triphosphate; Animals; Azaserine; Carcinoma, Ehrlich Tumor; Cell Line; Cell Nucleolus; Guanosine Triphosphate; Nucleotides, Cyclic; Purine Nucleosides; RNA, Ribosomal; RNA, Transfer | 1977 |
Utilization of L-glutamine in intercellular adhesion: ascites tumor and embryonic cells.
Topics: Animals; Azaserine; Carcinoma, Ehrlich Tumor; Cell Adhesion; Cell Aggregation; Cells, Cultured; Chick Embryo; Culture Media; Cytological Techniques; Glutamine; Indicators and Reagents; Liver Neoplasms; Mice; Norleucine; Retina; Sarcoma 180; Time Factors; Trypsin | 1973 |
Mechanism of inhibition of DNA synthesis in Ehrlich ascites tumour cells by diazoacetyl glycine-amide.
Topics: Amides; Animals; Azaserine; Azo Compounds; Carcinoma, Ehrlich Tumor; DNA Nucleotidyltransferases; DNA, Neoplasm; Glycine; Male; Mice; Neoplasm Proteins; Neoplasm Transplantation; Templates, Genetic; Thymidine; Thymidine Kinase; Thymine Nucleotides; Time Factors; Transplantation, Homologous; Tritium | 1973 |
Inhibition of the phosphoribosyl-formylglycineamidine synthetase of Ehrlich ascites tumor cells by glutamine analogues.
Topics: Animals; Azaserine; Carcinoma, Ehrlich Tumor; Diazooxonorleucine; Glutamine; Glycine; Kinetics; Ligases; Osmolar Concentration; Parabens; Pentosephosphates; Protein Binding | 1972 |
Combination therapy of animal tumors with L-asparaginase and antagonists of glutamine or glutamic acid.
Topics: Amino Acids; Aminobutyrates; Animals; Asparaginase; Azaserine; Body Weight; Carcinoma 256, Walker; Carcinoma, Ehrlich Tumor; Drug Synergism; Excitatory Amino Acid Antagonists; Female; Glutamine; Hexoses; Male; Melanoma; Mice; Neoplasms, Experimental; Rats | 1970 |
Nucleotide metabolism in Ehrlich ascites carcinoma cells.
Topics: Adenine; Animals; Azaserine; Carbon Isotopes; Carcinoma, Ehrlich Tumor; Cell-Free System; Cytosine Nucleotides; Electrophoresis; Glucose; Glutamine; Nucleosides; Nucleotides; Phosphorus Isotopes; Phosphotransferases; Ribose; RNA, Neoplasm; Uracil; Uridine | 1969 |
[Studies on the pharmacological characterization of a permanent in vitro growing strain of Ehrlich ascites tumor cells].
Topics: Animals; Antineoplastic Agents; Azaserine; Busulfan; Carcinoma, Ehrlich Tumor; Colchicine; Culture Techniques; Cyclophosphamide; Depression, Chemical; Diethylstilbestrol; Hydrazines; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Thiotepa; Triaziquone; Urethane | 1968 |
Mode of action of alanosine.
Topics: Adenine; Animals; Antifungal Agents; Antiviral Agents; Aspartic Acid; Azaserine; Carbon Isotopes; Carcinoma, Ehrlich Tumor; Depression, Chemical; Formates; Glutamine; Glycine; Guanine; Leucine; Nitrosamines; Nucleotides; Propionates; RNA, Neoplasm; Thymidine; Tritium; Uridine | 1968 |
Further studies on the metabolic effects of 9-beta-D-arabinofuranosyl-9-H-purine-6-thiol.
Topics: Abnormalities, Drug-Induced; Animals; Azaserine; Carcinoma, Ehrlich Tumor; DNA, Neoplasm; Female; Glucosyltransferases; Leukemia L1210; Mammary Neoplasms, Experimental; Mercaptopurine; Mice; Nucleosides; Oxidoreductases; Phosphotransferases; Pregnancy; Pregnancy, Animal; Sarcoma 180; Sarcoma, Experimental | 1967 |
[On the antagonism between the inhibitors of the biosynthesis of purines: azaserine and cycloserine, and the natural formiminated derivatives during the in vivo growth of cells of the Ehrlich ascites tumor].
Topics: Amides; Animals; Antimetabolites; Azaserine; Carcinoma, Ehrlich Tumor; Cycloserine; Glutamates; Male; Mice; Purines | 1966 |
Inhibitory effects of the arabinosides of 6-mercaptopurine and cytosine on purine and pyrimidine metabolism.
Topics: Animals; Azaserine; Carcinoma, Ehrlich Tumor; Mercaptopurine; Mice; Purines; Pyrimidines | 1966 |
Antitumor effects of methylglyoxal-bis(N-4-methylthiosemicarbazone) and their potentiation in pyridoxine-deficient animals.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Azaserine; Carcinoma 256, Walker; Carcinoma, Ehrlich Tumor; Diet; Drug Synergism; Female; Leukemia, Experimental; Lymphoma, Non-Hodgkin; Mice; Neoplasms, Experimental; Osteosarcoma; Sarcoma 180; Sarcoma, Experimental; Thiosemicarbazones; Vitamin B 6 Deficiency | 1965 |
Initial steps in pyrimidine synthesis in Ehrlich ascites carcinoma in vitro. 1. Factors affecting the incorporation of 14C-bicarbonate into carbon 2 of the uracil ring of the acid-soluble nucleotides of intact cells.
Topics: Ammonia; Animals; Azaserine; Bicarbonates; Carbamates; Carcinoma, Ehrlich Tumor; Glucose; Glutamine; In Vitro Techniques; Orotic Acid; Phosphates; Serine; Uracil; Uracil Nucleotides | 1965 |
Comparative effects of glutamine analogues on protein metabolism of 6C3H-ED and Ehrlich ascites carcinoma.
Topics: Amides; Animals; Azaserine; Azides; Carcinoma, Ehrlich Tumor; Diazooxonorleucine; Glutamine; Hydroxamic Acids; In Vitro Techniques; Isoleucine; Lymphoma, Non-Hodgkin; Methionine; Methionine Sulfoximine; Neoplasm Proteins; Sarcoma, Experimental; Valine | 1965 |
EXPERIMENTAL CHEMOTHERAPY STUDIES. V. THE COLLATERAL SENSITIVITY TO ALKYLATING AGENTS OF SEVERAL ANTIMETABOLITE-RESISTANT ASCITES TUMORS IN MICE.
Topics: Alkylating Agents; Animals; Antimetabolites; Antineoplastic Agents; Ascites; Azaserine; Carcinoma, Ehrlich Tumor; Cyclophosphamide; Fluorouracil; Leukemia L1210; Leukemia, Experimental; Methotrexate; Mice; Neoplasms; Neoplasms, Experimental; Nitrogen Mustard Compounds; Pharmacology; Research; Thioguanine; Thiotepa; Toxicology | 1964 |
ENHANCEMENT OF THIOINOSINATE SYNTHESIS IN THE EHRLICH ASCITES CARCINOMA BY PRIOR TREATMENT WITH 6-MERCAPTOPURINE OR AZASERINE.
Topics: Adenine Nucleotides; Animals; Ascites; Azaserine; Carcinoma; Carcinoma, Ehrlich Tumor; Chromatography; Histocytochemistry; Mercaptopurine; Metabolism; Mice; Neoplasms, Experimental; Nucleotides; Pharmacology; Phosphoric Monoester Hydrolases; Research | 1964 |
GROWTH INHIBITION OF A SPECTRUM OF TRANSPLANTED MOUSE TUMORS BY COMBINATIONS OF INHIBITORS OF NUCLEIC ACID BIOSYNTHESIS AND ALKYLATING AGENTS.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Azaguanine; Azaserine; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; DNA; DNA, Neoplasm; Fluorouracil; Idoxuridine; Liver Neoplasms; Lymphoma; Lymphoma, Non-Hodgkin; Mercaptopurine; Mice; Neoplasms, Experimental; Nitrogen Mustard Compounds; Nucleosides; Nucleotides; Purines; Research; RNA; RNA, Neoplasm; Sarcoma 180; Thioguanine; Uracil Mustard | 1963 |
METABOLIC EFFECTS OF 9-BUTYL-6-THIOGUANINE IN VIVO.
Topics: Adenine; Adenine Nucleotides; Animals; Antineoplastic Agents; Azaserine; Carcinoma, Ehrlich Tumor; DNA; DNA, Neoplasm; Glycine; Metabolism; Mice; Nucleic Acids; Proteins; Purines; Research; RNA; RNA, Neoplasm; Thioguanine | 1963 |
Treatment of ascites tumors with 4-aminopyrazolo (3,4-d)pyrimidine alone and in combination with azaserine, thioguanine, and 6-mercaptopurine.
Topics: Animals; Antineoplastic Agents; Ascites; Azaserine; Carcinoma, Ehrlich Tumor; Humans; Mercaptopurine; Neoplasms, Experimental; Pyrimidines; Thioguanine | 1961 |
Inhibition of ascites tumor growth by 4-aminopyrazolo-(3,4-d)pyrimidine in combination with azaserine, 6-mercaptopurine, and thioguanine.
Topics: Animals; Ascites; Azaserine; Azoles; Carcinoma, Ehrlich Tumor; Humans; Mercaptopurine; Neoplasms; Neoplasms, Experimental; Pyrimidines; Serine; Thioguanine | 1960 |
Early cell death due to azaserine treatment of Ehrlich ascites tumor cells: a histochemical comparison of histone with DNA and total protein.
Topics: Animals; Antineoplastic Agents; Azaserine; Carcinoma, Ehrlich Tumor; Cell Death; DNA; Histones; Humans | 1960 |
Cytochemical effects of azaserine and DON on ribonucleic acid of Ehrlich ascites tumor cells.
Topics: Animals; Antineoplastic Agents; Azaserine; Biochemical Phenomena; Carcinoma, Ehrlich Tumor; Diploidy; Leucine; Neoplasms; RNA | 1958 |
Cytochemical effects of azaserine on Ehrlich ascites tumor cells; action on deoxyribose nucleic acid (DNA) and total protein.
Topics: Animals; Antineoplastic Agents; Azaserine; Carcinoma, Ehrlich Tumor; Deoxyribose; DNA; Neoplasms; Nucleic Acids; Proteins; Serine | 1957 |
The influence of azaserine and 6-mercaptopurine on the in vivo metabolism of ascites tumor cells.
Topics: Animals; Anti-Bacterial Agents; Ascites; Azaserine; Carcinoma, Ehrlich Tumor; Mercaptopurine; Neoplasms; Purines | 1956 |